These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 11042693

  • 1. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 2. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 3. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 4. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.
    Oncogene; 1994 Feb 02; 9(2):405-15. PubMed ID: 8290253
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 6. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q, Hung FC, Fromm L, Overbeek PA.
    Invest Ophthalmol Vis Sci; 2000 Dec 25; 41(13):4223-31. PubMed ID: 11095619
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.
    Cancer Res; 2002 Jun 01; 62(11):3276-81. PubMed ID: 12036945
    [Abstract] [Full Text] [Related]

  • 8. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP, Sargent LM, Babcock K, Kinunen N, Pitot HC.
    Mol Carcinog; 2004 Jul 01; 40(3):150-9. PubMed ID: 15224347
    [Abstract] [Full Text] [Related]

  • 9. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A.
    Nat Cell Biol; 2001 Jan 01; 3(1):1-7. PubMed ID: 11146619
    [Abstract] [Full Text] [Related]

  • 10. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, Casabona D, Frau M, Seddaiu MA, Feo F.
    Hepatology; 2002 Jun 01; 35(6):1341-50. PubMed ID: 12029619
    [Abstract] [Full Text] [Related]

  • 11. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 01; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 12. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, Jacks T.
    Nat Genet; 1998 Apr 01; 18(4):360-4. PubMed ID: 9537419
    [Abstract] [Full Text] [Related]

  • 13. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL, Dong YB, Elliott MJ, Liu TJ, McMasters KM.
    Clin Cancer Res; 2000 Apr 01; 6(4):1579-89. PubMed ID: 10778992
    [Abstract] [Full Text] [Related]

  • 14. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.
    Oncogene; 2001 Aug 30; 20(38):5341-9. PubMed ID: 11536046
    [Abstract] [Full Text] [Related]

  • 15. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK, Liu TJ, Frederick MJ, Clayman GL.
    Clin Cancer Res; 1998 Sep 30; 4(9):2265-72. PubMed ID: 9748148
    [Abstract] [Full Text] [Related]

  • 16. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y, Zacksenhaus E.
    Oncogene; 2000 Dec 07; 19(52):6065-73. PubMed ID: 11146559
    [Abstract] [Full Text] [Related]

  • 17. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM, Fisher SM, Conti CJ, Johnson DG.
    Oncogene; 1998 Mar 12; 16(10):1267-76. PubMed ID: 9546428
    [Abstract] [Full Text] [Related]

  • 18. E2F-1-induced p53-independent apoptosis in transgenic mice.
    Holmberg C, Helin K, Sehested M, Karlström O.
    Oncogene; 1998 Jul 16; 17(2):143-55. PubMed ID: 9674698
    [Abstract] [Full Text] [Related]

  • 19. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M.
    Clin Cancer Res; 2000 Jul 16; 6(7):2851-9. PubMed ID: 10914734
    [Abstract] [Full Text] [Related]

  • 20. Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.
    Hengstschläger M, Hölzl G, Hengstschläger-Ottnad E.
    Oncogene; 1999 Jan 21; 18(3):843-8. PubMed ID: 9989838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.